Two Mount Sinai Luminaries Are Elected To the National Academy of Medicine

Alison M. Goate, DPhil

Alison M. Goate, DPhil

Two prominent researchers at the Icahn School of Medicine at Mount Sinai, Alison M. Goate, DPhil, and Lynne D. Richardson, MD, recently were elected to the prestigious National Academy of Medicine, formerly named the Institute of Medicine. Dr. Goate is the Willard T.C. Johnson Research Professor of Neurogenetics, and Director of the Ronald M. Loeb Center on Alzheimer’s Disease. Dr. Richardson is Professor and Vice Chair of Emergency Medicine, and Professor of Population Health Science and Policy. (more…)

Second-Hand Smoke More Pervasive Than People Think

Many people who are exposed to second-hand cigarette smoke on a day-to-day basis do not realize it, according to newly published research by physicians at the Icahn School of Medicine at Mount Sinai. Yet exposure to this carcinogen carries an increased risk for heart disease and lung cancer, and mortality by an average of three years, exceeding even that of former smokers who are not exposed.

These were among the findings reported by Raja M. Flores, MD, and Emanuela Taioli, MD, PhD, in a study that appeared in the October issue of Carcinogenesis. (more…)

Research Reveals New Insights Into the Preclinical Stages of Inflammatory Bowel Disease

Study researchers Jean-Frédéric Colombel, MD, and Joana Torres, MD, postdoctoral fellow, Department of Medicine (Gastroenterology)

Study researchers Jean-Frédéric Colombel, MD, and Joana Torres, MD, postdoctoral fellow, Department of Medicine (Gastroenterology)

Years before inflammatory bowel disease (IBD) is diagnosed and symptoms exist, biomarkers are already circulating that can help predict risk not only of disease development but also of complications, according to recent findings by Mount Sinai scientists and partner organizations. For the first time, researchers found that these markers, in the form of antimicrobial antibodies, were present in serum up to six years before diagnosis of IBD, and that the higher number of antibodies indicated a greater chance of complications at or around the time of diagnosis. (more…)

EANS 2014: Virtual Reality Simulations in Brain Surgery

Anthony Costa PhD, Dr. Errol Gordon, Dr. Joshua Bederson and Zach Lorsch

Anthony Costa PhD, Dr. Errol Gordon, Dr. Joshua Bederson and Zach Lorsch

Mount Sinai’s Neurosurgery team and other presenters pose a critical question: What if your surgeon already did your surgery before you came to the operating room?

Neurosurgeons, residents and researchers congregated in the historic city of Prague to discover the latest developments, innovative techniques, and advanced practices in neurosurgery at the European Association of Neurosurgical Societies (EANS). Kicking off the educational activities in this scientific arena was Joshua B. Bederson, MD, Chair of Neurosurgery, who moderated, presented at, and helmed the Virtual Reality Simulations and Augmented Reality Applications in Brain Surgery pre-course, alongside several of his team members and neurosurgery experts from around the globe. Together they sought to answer a question posed by Bernard R. Bendok, MD, Professor in Neurological Surgery at Northwestern University Feinberg School of Medicine, in his Overview of Simulation in Neurosurgery presentation, ‘What if your surgeon already did your surgery before you came to the operating room?’ (more…)